Leukemia regression by vascular disruption and antiangiogenic therapyGerard J. Madlambayan, Christopher R. Cogle, Marda Jorgensen et al.|Blood|2010Cited by 77
Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive triggerGerard J. Madlambayan, Christopher R. Cogle, Jason M. Butler et al.|Blood|2009Cited by 59
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cellsM Kim, Grant McFadden, Gerard J. Madlambayan et al.|Leukemia|2009Cited by 51
AML Regression by Vascular Disruption with OXi4503 and Anti-Angiogenesis with Bevacizumab.Gerard J. Madlambayan, Christopher R. Cogle, Dietmar W. Siemann et al.|Blood|2009Cited by 0